Thread
:
Biohaven Advances Regulatory Efforts for BHV-0223, a Sublingual Form of ALS Therapy R
View Single Post
05-02-2017, 09:24 PM
MuonOne
Grand Magnate
Join Date: Feb 2007
Posts: 3,400
MuonOne
Grand Magnate
Join Date: Feb 2007
Posts: 3,400
Biohaven Advances Regulatory Efforts for BHV-0223, a Sublingual Form of ALS Therapy R
Biohaven Advances Regulatory Efforts for BHV-0223, a Sublingual Form of ALS Therapy Rilutek
ALS Therapy Rilutek's Sublingual Version BHV- 223 is Focus of Biohaven Regulatory Efforts
Reply With Quote
MuonOne
View Public Profile
Find More Posts by MuonOne
MuonOne
View Public Profile
Find More Posts by MuonOne